Company: DMAC
Filing Date: 2025-03-28
Form Type: DEF 14A
Source: 0001437749-25-009696
Chunk: 24

Company: DiaMedica Therapeutics Inc.
Filing Date: 2025-03-28
Form: DEF 14A
Chunk 24
---
 reflecting beneficial ownership as of June 28, 2024. John Fichthorn is the manager of Dialectic LS Manager LLC, the controlling entity of Dialectic Life Sciences SPV LLC. |

<div align='center'>20</div>

Security Ownership of Management

The table below sets forth information known to us regarding the beneficial ownership of our common shares as of March 18, 2025, by:

| ● | each of our current directors; |

| ● | each of the individuals named in the Summary Compensation Table under “Executive Compensation” on page 47; and |

| ● | all of our current directors and executive officers as a group. |

To our knowledge, each person named in the table has sole voting and investment power with respect to all of the securities shown as beneficially owned by such person, as determined by the rules of the SEC, except as otherwise set forth in the notes to the table and subject to community property laws, where applicable. The SEC has defined “beneficial” ownership of a security to mean the possession, directly or indirectly, of voting power and/or investment power. A shareholder is also deemed to be, as of any date, the beneficial owner of all securities that such shareholder has the right to acquire within 60 days after that date through (i) the exercise of any option, warrant or right; (ii) the conversion of a security; (iii) the power to revoke a trust, discretionary account or similar arrangement; or (iv) the automatic termination of a trust, discretionary account or similar arrangement. However, such unissued shares of common shares are not deemed to be outstanding for calculating the percentage of common shares owned by any other person.

Unless otherwise indicated below, the address for each beneficial owner listed is c/o DiaMedica Therapeutics Inc., 301 Carlson Parkway, Suite 210, Minneapolis, Minnesota 55305.

| Title of Class | Name of Beneficial Owner                                             |     | Amount and Nature 
 of Beneficial     
 Ownership(1)      |           |    |     | Percent of 
 Class(2)   |      |
| Common Shares  | Michael Giuffre, M.D.                                                |     |                   |   543,102 | -3 |     |            | 1.3% |
| Common Shares  | Richard Kuntz, M.D., M.Sc.                                           |     |                   |    58,064 |    |     |            | *    |
| Common Shares  | Tanya Lewis